Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
New Horizons in Translational Research
Tell a Friend About This EventTell a Friend
 

Considering the current pace of technological advancement, we are poised on the brink of a medical revolution. Advances in genomics, transcriptomics, proteomics and metabolomics will soon allow us to routinely customize medical treatments based on an understanding of our internal biochemistry.

5/20/2014
When: Tuesday, May 20
9:00 AM - 1:30 PM
Where: Virginia Biotechnology Research Park
Robert Ball Conference Room
800 E. Leigh St.
Richmond, Virginia  23227
United States
Contact: Sherri Halloran
804-643-6360


Online registration is closed.
« Go to Upcoming Event List  

New Horizons in Translational Research
Lipidomics and Metabolomics: clinical needs, research advances and commercial opportunities
(Mini-Symposium, Tuesday May 20th, 9.00 am to 1.30 pm)

 

Considering the current pace of technological advancement, we are poised on the brink of a medical revolution. Advances in genomics, transcriptomics, proteomics and metabolomics will soon allow us to routinely customize medical treatments based on an understanding of our internal biochemistry. However, despite the great promises afforded by these technologies and their increasing availability, many fundamental questions that aid in the diagnosis and treatment of human diseases still remain unanswered. A significant factor in this problem is inadequate communication between physicians, basic scientists and also the biomedical industry regarding the availability and applicability of specialized methodologies to answer such questions. As a result, many of these specific questions and conundrums regarding human health and disease are not well known outside of the physician communities and thus often fail to be addressed using existing technology. On the other hand a majority of research in basic science are not directly targeting these specific high impact questions related to human health and disease. Furthermore, existing basic science research that target such questions are often carried out without considering the requirements that need to be addressed in order to be developed into a successful and commercially viable product, thus necessitating many years of additional research and development. This lack of communication, and not the availability of technology is a major limiting factor in the translation of relevant findings into applicable treatments and tests. This mini-symposium is an attempt at opening these channels of communication and also to introduce the availability of new technology to answer medically relevant questions. In this regards, the primary goal of this symposium are;


1. To understand questions related to human health and disease from a physician’s point of view.
2. Demonstrate how lipidomic and metabolomic approaches can be applied to address these questions.
3. Introduce the most advanced technologies available for application of these approaches.

To achieve these goals, a panel of 6 speakers consisting of two physicians, two basic scientists, and two industry experts in lipidomics and metabolomics will provide an outline of the medically relevant questions, the basic science research currently being carried out to answer those questions and the technology available to answer those questions.

 

Symposium Agenda

 

9.00 am         Registration

9.15 am – 9.30 am     Jeff Gallagher                             Welcome; the opportunities and challenges
                                CEO, Virginia Bio

9.30 am – 10.00 am     Dayanjan Wijesinghe (Ph.D.)     Clinical applications of lipidomics: Potential for disease                                                                                     prevention, diagnosis and treatment

10.00 am – 10.30 am     Charles Chalfant (Ph.D.)          Bioactive lipid mediators in septicemia

10.30 am – 11.00 am     Paul Baker (Ph.D.)                 Current technological advances in lipidomics

11.00 am – 11.30 am     Baljith Ubhi (Ph.D.)                 Current technological advances in metabolomics

11.30 am – 12.00 pm     Bruce D Spiess (MD)              Inflammation in Cardiac Surgery: A Model of Biologic    

                                                                                Complexity Awaiting Lipid Insight


12:00 pm – 12:30 pm    Mary Ann Peberdy (MD)          Improving survival following cardiac arrest: Where do we go 

                                                                                from here?


12:30 pm – 1:00 pm     Lunch and networking

1:00 pm – 1:30 pm      Panel discussion, Q and A

 


more Events

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

12/14/2016
Webinar; Investor Tax Credits

Premium Members

Membership Software Powered by YourMembership  ::  Legal